Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online® are pleased to announce their co-organization of RDD® Europe 2023, which will be held in-person from Tuesday, May 2 to Friday, May 5, 2023 at the Palais des Congrès Antipolis in Antibes (Nice), France.
As one of the largest international respiratory health conferences, RDD Europe 2023 is the go-to event for major organizations, start-ups and individuals active in research and development of medication delivery to the lungs and nose.
This year’s event will feature five Knowledge Spaces, each incorporating speakers, workshops, posters and exhibitors:
- From Bench to Bedside
- Advancing Aqueous – Navigating Nasal
- Building a Sustainable Future
- Inspiring Dry Powder Inhalation
- Advanced Inhalation: Data Driven Design.
Knowledge spaces will give attendees maximum opportunity to find their next collaborator, customer or project, and Explore with Expert sessions will provide additional insights.
All posters and table exhibits hosted by key players in the pulmonary and nasal drug delivery field will be accessible to in-person delegates throughout the conference, and the lunchtime sessions on May 4 and 5 will be the central hub for maximized learning and interaction. Posters on the Podium on May 4 will feature poster presenters selected by the editorial team. All speaker and poster presentations are accompanied by peer-reviewed scientific papers.
Twelve signature Workshop sessions, each repeated three times, will take place on May 3, allowing delegates to tailor their conference experience to their unique interests in a small-group setting. So as not to miss out on the other nine sessions, synopses of each workshop will be available on-demand on the RDD Europe 2023 website.
The conference will open with a Welcome Cocktail Reception on the evening of May 2, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Antibes on Thursday, May 4.
As a global leader in OINDP device design and technology, Aptar Pharma is proud to be a Co-Organizer of RDD Europe 2023 and will host a workshop on May 3. Entitled “Accelerating and derisking the development of low global warming potential (GWP) pMDIs,” this workshop will be co-presented by Chris Baron, Director Business Development Pulmonary Category, Aptar Pharma, and Lucas Silva, Head of Analytical Development, R&D Pharma Services, Nanopharm, an Aptar Pharma company.
Conference registration includes extended access (April 25 to June 30, 2023) to Company Profiles, papers, on-demand presentations and delegate messaging via the RDD website. This content is as accessible to online delgates as it is to those attending in-person.
“I’m thrilled to be returning to Antibes for the first post-pandemic RDD Europe conference,” commented Richard Dalby, one of the conference organizers. “Scientists, engineers, clinicians and business professionals in industry, academia and government worked tirelessly on inhaled and nasal drug delivery while travel was impossible, so there’s a lot of new information being presented now that we are meeting face-to-face again.”
Added Carolyn Penot, Director of Operational Marketing at Aptar Pharma, “Knowledge Spaces, extended engagement and on-demand expert presentations were born during the pandemic, and they have matured to become integral features of our in-person conference. With these enhancements to our industry-leading conference, we look forward to reuniting in-person at RDD Europe 2023.”
To register as a delegate or learn more about sponsorship opportunities, visit the RDD Europe 2023 website.
Download full RDD Europe 2023 Press Release.